Psychedelics in medicine - a call for educational action

Authors

  • Daniel Shane University of Toronto
  • Matthew Cho University of Toronto
  • Sabrina Akhtar University of Toronto

DOI:

https://doi.org/10.36834/cmej.78844

References

van Amsterdam J, van den Brink W. The therapeutic potential of psilocybin: a systematic review. Expert Opin Drug Saf. 2022 Jun 3;21(6):833-40. https://doi.org/10.1080/14740338.2022.2047929. DOI: https://doi.org/10.1080/14740338.2022.2047929

Dyck E. Flashback: psychiatric experimentation with LSD in historical perspective. Can J Psychiatry. 2005 Jun 1;50(7):381-8. https://doi.org/10.1177/070674370505000703. DOI: https://doi.org/10.1177/070674370505000703

Belouin SJ, Henningfield JE. Psychedelics: where we are now, why we got here, what we must do. Neuropharm. 2018 Nov;142:7-19. https://doi.org/10.1016/j.neuropharm.2018.02.018. DOI: https://doi.org/10.1016/j.neuropharm.2018.02.018

Zannese K. High time? Psychedelics on cannabis-like fast track to legalization. Can Med Assoc J. 2022 Dec 19;194(49):E1695-6. https://doi.org/10.1503/cmaj.1096029. DOI: https://doi.org/10.1503/cmaj.1096029

Wang K, Sun Y, Nava B, Sampiere L, Jacobs RJ. Predictors of medical students' perceptions of psilocybin-assisted therapy for use in medical practice. Cureus. 15(4):e37450.

Downloads

Published

2024-03-18

How to Cite

1.
Shane D, Cho M, Akhtar S. Psychedelics in medicine - a call for educational action. Can. Med. Ed. J [Internet]. 2024 Mar. 18 [cited 2024 Dec. 21];15(4):132-3. Available from: https://journalhosting.ucalgary.ca/index.php/cmej/article/view/78844

Issue

Section

Commentary and Opinions